Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Stem Cell Reports
2013 Jun 04;11:5-17. doi: 10.1016/j.stemcr.2013.05.001.
Show Gene links
Show Anatomy links
From Stealing Fire to Cellular Reprogramming: A Scientific History Leading to the 2012 Nobel Prize.
Lensch MW
,
Mummery CL
.
???displayArticle.abstract???
Cellular reprogramming was recently "crowned" with the award of the Nobel Prize to two of its groundbreaking researchers, Sir John Gurdon and Shinya Yamanaka. The recent link between reprogramming and stem cells makes this appear almost a new field of research, but its historical roots have actually spanned more than a century. Here, the Nobel Prize in Physiology or Medicine 2012 is placed in its historical context.
Figure 1. Winners of the 2012 Nobel Prize in Physiology or Medicine: Sir John B. Gurdon and Shinya YamanakaThe photo was taken at the ISSCR-Roddenberry International Symposium on Cellular Reprogramming only 10 days after the announcement of the laureates for 2012. Photo credit: Chris Goodfellow/Gladstone Institutes.
Figure 2. Relationships between Pluripotent Stem Cells and Embryos: 50 Years of History in MicePluripotent stem cells can arise from NT-derived (cloned) blastocysts, fertilized embryos or teratocarcinomas, spontaneous tumors of the testis, or tumors induced by transferring early embryos to extrauterine sites. ESCs and EC cells will form chimeras if introduced into preimplantation embryos that are transferred to a pseudopregnant female mother. ESCs will be chimeric in the germline and give rise to sperm and eggs, but EC cells do not chimerize the germline. A less stringent test for pluripotency of ESCs than germline contribution is the ability to form benign teratomas after injection in immune-deficient mice. This test is also used to demonstrate pluripotency in human ESCs. A more stringent test is “tetraploid complementation,” where the entire postnatal animal is ESC derived. Teratocarcinomas are thought to derive spontaneously from deregulated primordial germ cells (PGCs) that give rise to the gametes. Pluripotent stem cell lines can also be derived as embryonic germ (EG) cells directly from PGCs. mEC, mouse embryonal carcinoma; mESC, mouse embryonic stem cell; miPSC, mouse induced pluripotent stem cell; mEG, mouse embryonic germ.
Figure 3. Derivation and Use of Human Pluripotent Stem CellsHuman ES cells (hESCs) and iPS cells (hiPSCs) have immediate applications in modeling disease, drug discovery, and safety pharmacology. Genetic or other correction provides the appropriate control cells for these studies. hESCs can be targeted genetically to create disease models and introduce different mutations on an isogenic background. Alternatively, disease-specific hESCs can be derived from embryos that are rejected after preimplantation genetic diagnosis (PGD). Longer-term applications are thought to be in cell transplantation therapy. The prototype human pluripotent stem cells are EC stem cells (hECs) derived from spontaneous teratocarcinomas. As in mice, pluripotent stem cells can also be derived from primordial germ cells in humans as human embryonic germ cells (hEGCs), but these have usually not become stable lines (data not shown).
Ambasudhan,
Direct reprogramming of adult human fibroblasts to functional neurons under defined conditions.
2011, Pubmed
Ambasudhan,
Direct reprogramming of adult human fibroblasts to functional neurons under defined conditions.
2011,
Pubmed
Andrews,
Antigen expression by somatic cell hybrids of a murine embryonal carcinoma cell with thymocytes and L cells.
1980,
Pubmed
Andrews,
From teratocarcinomas to embryonic stem cells.
2002,
Pubmed
Biggers,
IVF and embryo transfer: historical origin and development.
2012,
Pubmed
Bongso,
Isolation and culture of inner cell mass cells from human blastocysts.
1994,
Pubmed
Boyer,
Core transcriptional regulatory circuitry in human embryonic stem cells.
2005,
Pubmed
Briggs,
Transplantation of Living Nuclei From Blastula Cells into Enucleated Frogs' Eggs.
1952,
Pubmed
Brinster,
The effect of cells transferred into the mouse blastocyst on subsequent development.
1974,
Pubmed
Campbell,
Sheep cloned by nuclear transfer from a cultured cell line.
1996,
Pubmed
Cowan,
Nuclear reprogramming of somatic cells after fusion with human embryonic stem cells.
2005,
Pubmed
Davis,
Expression of a single transfected cDNA converts fibroblasts to myoblasts.
1987,
Pubmed
Dimos,
Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons.
2008,
Pubmed
Do,
Nuclei of embryonic stem cells reprogram somatic cells.
2004,
Pubmed
Duncan,
Stem cells and liver regeneration.
2009,
Pubmed
Eggan,
Mice cloned from olfactory sensory neurons.
2004,
Pubmed
Evans,
Establishment in culture of pluripotential cells from mouse embryos.
1981,
Pubmed
Finch,
RETENTION OF MULTIPLE DEVELOPMENTAL POTENTIALITIES BY CELLS OF A MOUSE TESTICULAR TERATOCARCINOMA DURING PROLONGED CULTURE in vitro AND THEIR EXTINCTION UPON HYBRIDIZATION WITH CELLS OF PERMANENT LINES.
1967,
Pubmed
GURDON,
Factors responsible for the abnormal development of embryos obtained by nuclear transplantation in Xenopus laevis.
1960,
Pubmed
,
Xenbase
GURDON,
The developmental capacity of nuclei taken from intestinal epithelium cells of feeding tadpoles.
1962,
Pubmed
,
Xenbase
Graf,
Historical origins of transdifferentiation and reprogramming.
2011,
Pubmed
Gurdon,
The developmental capacity of nuclei transplanted from keratinized skin cells of adult frogs.
1975,
Pubmed
,
Xenbase
Gurdon,
"Fertile" intestine nuclei.
1966,
Pubmed
Hochedlinger,
Monoclonal mice generated by nuclear transfer from mature B and T donor cells.
2002,
Pubmed
Jami,
Lack of expression of differentiation in mouse teratoma-fibroblast somatic cell hybrids.
1973,
Pubmed
KLEINSMITH,
MULTIPOTENTIALITY OF SINGLE EMBRYONAL CARCINOMA CELLS.
1964,
Pubmed
Kim,
An extended transcriptional network for pluripotency of embryonic stem cells.
2008,
Pubmed
Lassar,
Transfection of a DNA locus that mediates the conversion of 10T1/2 fibroblasts to myoblasts.
1986,
Pubmed
Lensch,
Teratoma formation assays with human embryonic stem cells: a rationale for one type of human-animal chimera.
2007,
Pubmed
Lensch,
The terminology of teratocarcinomas and teratomas.
2007,
Pubmed
Loh,
The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells.
2006,
Pubmed
Lopes,
Embryonic diapause and its regulation.
2004,
Pubmed
Maherali,
Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution.
2007,
Pubmed
Martin,
The morphology and growth of a pluripotent teratocarcinoma cell line and its derivatives in tissue culture.
1974,
Pubmed
Martin,
Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells.
1981,
Pubmed
Matveeva,
In vitro and in vivo study of pluripotency in intraspecific hybrid cells obtained by fusion of murine embryonic stem cells with splenocytes.
1998,
Pubmed
Mayer,
Demethylation of the zygotic paternal genome.
2000,
Pubmed
Miller,
Pluripotent teratocarcinoma-thymus somatic cell hybrids.
1976,
Pubmed
Morris,
Developmental plasticity is bound by pluripotency and the Fgf and Wnt signaling pathways.
2012,
Pubmed
Nagy,
Embryonic stem cells alone are able to support fetal development in the mouse.
1990,
Pubmed
Noggle,
Human oocytes reprogram somatic cells to a pluripotent state.
2011,
Pubmed
Okita,
Generation of germline-competent induced pluripotent stem cells.
2007,
Pubmed
Park,
Reprogramming of human somatic cells to pluripotency with defined factors.
2008,
Pubmed
Park,
Disease-specific induced pluripotent stem cells.
2008,
Pubmed
Smith,
Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides.
1988,
Pubmed
Steptoe,
Birth after the reimplantation of a human embryo.
1978,
Pubmed
Stevens,
Spontaneous Testicular Teratomas in an Inbred Strain of Mice.
1954,
Pubmed
Stitzel,
Regulation of the oocyte-to-zygote transition.
2007,
Pubmed
Tachibana,
Human embryonic stem cells derived by somatic cell nuclear transfer.
2013,
Pubmed
Tada,
Nuclear reprogramming of somatic cells by in vitro hybridization with ES cells.
2001,
Pubmed
Tadros,
The maternal-to-zygotic transition: a play in two acts.
2009,
Pubmed
Takahashi,
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.
2006,
Pubmed
Takahashi,
Induction of pluripotent stem cells from adult human fibroblasts by defined factors.
2007,
Pubmed
Tapscott,
MyoD1: a nuclear phosphoprotein requiring a Myc homology region to convert fibroblasts to myoblasts.
1988,
Pubmed
Teilum,
Classification of endodermal sinus tumour (mesoblatoma vitellinum) and so-called "embryonal carcinoma" of the ovary.
1965,
Pubmed
Terada,
Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion.
2002,
Pubmed
Thomson,
Embryonic stem cell lines derived from human blastocysts.
1998,
Pubmed
Vierbuchen,
Direct conversion of fibroblasts to functional neurons by defined factors.
2010,
Pubmed
Viswanathan,
Selective blockade of microRNA processing by Lin28.
2008,
Pubmed
Wabl,
Lymphocytes of the toad Xenopus laevis have the gene set for promoting tadpole development.
1975,
Pubmed
,
Xenbase
Wakayama,
Cloning of mice to six generations.
2000,
Pubmed
Wakayama,
Full-term development of mice from enucleated oocytes injected with cumulus cell nuclei.
1998,
Pubmed
Wernig,
In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state.
2007,
Pubmed
Williams,
Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells.
1988,
Pubmed
Wilmut,
Viable offspring derived from fetal and adult mammalian cells.
1997,
Pubmed
Ying,
Changing potency by spontaneous fusion.
2002,
Pubmed
Yu,
Induced pluripotent stem cell lines derived from human somatic cells.
2007,
Pubmed